194 related articles for article (PubMed ID: 21459527)
41. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
42. Decreasing temporal lobe dose with five-field intensity-modulated radiotherapy for treatment of pituitary macroadenomas.
Parhar PK; Duckworth T; Shah P; DeWyngaert JK; Narayana A; Formenti SC; Shah JN
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):379-84. PubMed ID: 20015598
[TBL] [Abstract][Full Text] [Related]
43. Can protons improve SBRT for lung lesions? Dosimetric considerations.
Georg D; Hillbrand M; Stock M; Dieckmann K; Pötter R
Radiother Oncol; 2008 Sep; 88(3):368-75. PubMed ID: 18405986
[TBL] [Abstract][Full Text] [Related]
44. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma.
Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
Ann Oncol; 2013 Aug; 24(8):2113-8. PubMed ID: 23619032
[TBL] [Abstract][Full Text] [Related]
45. Temporal lobe toxicity analysis after proton radiation therapy for skull base tumors.
Pehlivan B; Ares C; Lomax AJ; Stadelmann O; Goitein G; Timmermann B; Schneider RA; Hug EB
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1432-40. PubMed ID: 22349042
[TBL] [Abstract][Full Text] [Related]
46. Multisegmented tangential breast fields: a rational way to treat breast cancer.
Gulybán A; Kovács P; Sebestyén Z; Farkas R; Csere T; Karácsonyi G; Dérczy K; Hideghéty K; Esik O
Strahlenther Onkol; 2008 May; 184(5):262-9. PubMed ID: 18427757
[TBL] [Abstract][Full Text] [Related]
47. Dose escalation with proton or photon radiation treatment for pancreatic cancer.
Bouchard M; Amos RA; Briere TM; Beddar S; Crane CH
Radiother Oncol; 2009 Aug; 92(2):238-43. PubMed ID: 19454367
[TBL] [Abstract][Full Text] [Related]
48. Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis.
Marucci L; Niemierko A; Liebsch NJ; Aboubaker F; Liu MC; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):551-5. PubMed ID: 15145175
[TBL] [Abstract][Full Text] [Related]
49. Short-course, intensity-modulated radiotherapy for localized prostate cancer.
Kupelian PA; Willoughby TR
Cancer J; 2001; 7(5):421-6. PubMed ID: 11693901
[TBL] [Abstract][Full Text] [Related]
50. Three-dimensional conformal radiotherapy versus intracavitary brachytherapy for salvage treatment of locally persistent nasopharyngeal carcinoma.
Zheng XK; Chen LH; Chen YQ; Deng XG
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):165-70. PubMed ID: 15337552
[TBL] [Abstract][Full Text] [Related]
51. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
52. Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer.
Vogelius IR; Westerly DC; Aznar MC; Cannon GM; Korreman SS; Mackie TR; Mehta MP; Bentzen SM
Acta Oncol; 2011 Aug; 50(6):772-6. PubMed ID: 21767173
[TBL] [Abstract][Full Text] [Related]
53. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx.
Clark CH; Bidmead AM; Mubata CD; Harrington KJ; Nutting CM
Radiother Oncol; 2004 Feb; 70(2):189-98. PubMed ID: 15028407
[TBL] [Abstract][Full Text] [Related]
54. Proton pencil beam scanning reduces secondary cancer risk in breast cancer patients with internal mammary chain involvement compared to photon radiotherapy.
Cartechini G; Fracchiolla F; Menegotti L; Scifoni E; La Tessa C; Schwarz M; Farace P; Tommasino F
Radiat Oncol; 2020 Oct; 15(1):228. PubMed ID: 33008412
[TBL] [Abstract][Full Text] [Related]
55. Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential.
Toltz A; Shin N; Mitrou E; Laude C; Freeman CR; Seuntjens J; Parker W; Roberge D
J Appl Clin Med Phys; 2015 Sep; 16(5):167–178. PubMed ID: 26699298
[TBL] [Abstract][Full Text] [Related]
56. Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy.
Yoon M; Shin DH; Kim J; Kim JW; Kim DW; Park SY; Lee SB; Kim JY; Park HJ; Park BK; Shin SH
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):637-46. PubMed ID: 20932690
[TBL] [Abstract][Full Text] [Related]
57. Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.
Hoppe BS; Flampouri S; Zaiden R; Slayton W; Sandler E; Ozdemir S; Dang NH; Lynch JW; Li Z; Morris CG; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1053-1059. PubMed ID: 24928256
[TBL] [Abstract][Full Text] [Related]
58. Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques.
Kozak KR; Katz A; Adams J; Crowley EM; Nyamwanda JA; Feng JK; Doppke KP; Delaney TF; Taghian AG
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1572-8. PubMed ID: 16863934
[TBL] [Abstract][Full Text] [Related]
59. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?
De Sanctis V; Bolzan C; D'Arienzo M; Bracci S; Fanelli A; Cox MC; Valeriani M; Osti MF; Minniti G; Chiacchiararelli L; Enrici RM
Radiat Oncol; 2012 Aug; 7():129. PubMed ID: 22857015
[TBL] [Abstract][Full Text] [Related]
60. A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk.
Koh ES; Tran TH; Heydarian M; Sachs RK; Tsang RW; Brenner DJ; Pintilie M; Xu T; Chung J; Paul N; Hodgson DC
Radiat Oncol; 2007 Mar; 2():13. PubMed ID: 17362522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
